Torquin, LLC
Records under this name other than patents Torquin, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Torquin, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,572,782 | Use of targeted oxidative therapeutic formulation in bone regeneration Lapsed on the fee record Ended Aug 11, 2013 · From the USPTO record | Lapsed on the fee record | Ended Aug 11, 2013 | From the USPTO record |
| US 6,884,797 | Targeted oxidative therapeutic formulation Lapsed on the fee record Ended Apr 26, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 26, 2013 | From the USPTO record |
| US 7,521,440 | Targeted oxidative therapeutic formulation Lapsed on the fee record Ended Apr 21, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 21, 2013 | From the USPTO record |
| US 6,790,463 | Uses of targeted oxidative therapeutic formulation in arteriosclerosis Lapsed on the fee record Ended Sep 14, 2012 · From the USPTO record | Lapsed on the fee record | Ended Sep 14, 2012 | From the USPTO record |
| US 7,414,044 | Use of targeted oxidative therapeutic formulation in treatment of type 2 diabetes Lapsed on the fee record Ended Aug 19, 2012 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2012 | From the USPTO record |
| US 5,817,630 | Glutathione antioxidant eye drops Term ended Term ended no later than Oct 6, 2018 · Low confidence | Term ended | Term ended no later than Oct 6, 2018 | Low confidence |